Cargando…
A Case Report of Post-Radiotherapy c-MYC-Positive Angiosarcoma of the Breast
Angiosarcoma of the breast is an unusual malignancy and carries a poor prognosis, with a 5-year overall survival rate ranging from 27 to 48%. Radiotherapy-induced angiosarcoma (RIAS) of the breast is very uncommon, with an estimated incidence of 1 in 1,000 cases of breasts treated with radiotherapy...
Autores principales: | Retter, Edna, Benn, Carol-Ann, Maske, Christopher, Rapoport, Bernardo Leon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921946/ https://www.ncbi.nlm.nih.gov/pubmed/35350806 http://dx.doi.org/10.1159/000521069 |
Ejemplares similares
-
Analysis of primary endocrine therapy in patients older than 70 years with breast cancer rejecting surgery from a single unit in South Africa including COVID-19 issues
por: Benn, Carol-Ann, et al.
Publicado: (2021) -
Key Roles for MYC, KIT and RET signaling in secondary angiosarcomas
por: Styring, E, et al.
Publicado: (2014) -
Aberrations in Angiogenic Signaling and MYC Amplifications are Distinguishing Features of Angiosarcoma
por: Kurisetty, Vittal, et al.
Publicado: (2013) -
MYC Amplification in Angiosarcoma Arising from an Arteriovenous Graft Site
por: Paral, Kristen M., et al.
Publicado: (2015) -
A South African Breast Implant-Associated Anaplastic Large Cell Lymphoma: Clinical Presentation and Six-Year Follow-Up
por: Grubnik, Alexandra, et al.
Publicado: (2022)